A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2014 |
| End Date: | March 2015 |
This is a safety and efficacy study of abicipar pegol in patients with neovascular
age-related macular degeneration to establish comparability between Japanese and
non-Japanese.
age-related macular degeneration to establish comparability between Japanese and
non-Japanese.
Inclusion Criteria:
- Diagnosis of wet age-related macular degeneration in at least 1 eye
- Best corrected visual acuity of 20/32 to 20/320 in the study eye and 20/200 or better
in the fellow eye
Exclusion Criteria:
- Hypersensitivity, allergy, or anaphylactic reaction to iodine
- Cataract or refractive surgery within the last 3 months
- History of vitrectomy
We found this trial at
1
site
Click here to add this to my saved trials
